Print Page | Close Window

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

June 28, 2016 - 10:26 a.m.
U.S. Food and Drug Administration Approves Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis CPrinter Friendly Version 
June 23, 2016 - 7:54 a.m.
European Commission Grants Marketing Authorization for Gilead’s Single Tablet Regimen Odefsey® (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) for the Treatment of HIVPrinter Friendly Version 

Upcoming Events

Monday, July 18, 2016 through Friday, July 22, 2016
21st International AIDS Conference
LocationDurban, South Africa
Monday, July 25, 2016
Second Quarter 2016 Gilead Sciences Earnings Conference Call
LocationFoster City, CA

Most Viewed Links

Updated 05/27/16
1.SEC Filings
2.Earnings
3.UBS Global Healthcare Conference
4.Annual Reports
5.Stock Information
* Data collected 05/19/16 - 05/26/16

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.